10 Precision Oncology Companies to Look Out for
According to statistics, the global precision oncology market is forecast to reach US$ 99.72 billion by 2027. Several established giants in the cancer genomics space like Illumina, Roche, Qiagen, Thermo Fisher Scientific, and Merck are positioned to soar even higher.
However, a number of promising startups that burst into the scene in the last decade and a half have attracted new capital and have extended newer technologies. Here we list 10 such precision oncology companies to look out for.
However, a number of promising startups that burst into the scene in the last decade and a half have attracted new capital and have extended newer technologies. Here we list 10 such precision oncology companies to look out for.
GO Prime with only $1.49 now
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23